Tag: FDA deficiency letters

Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them

by Arnold Kendrick

Learn the most common FDA deficiency letter findings in generic drug applications and how to avoid them. Get data-backed insights on dissolution, impurities, manufacturing, and bioequivalence issues that delay approval.

Recent-posts

Nitroglycerin vs Alternatives: Which Angina Treatment Works Best?

Oct, 11 2025

Opioids During Pregnancy: Risks, Withdrawal, and Monitoring

Jan, 1 2026

Corticosteroid Injections for Joint Pain: What They Do, How Long They Last, and When to Avoid Them

Jan, 5 2026

Risk-Benefit Statements in FDA Labels: What Patients Need to Know

Feb, 11 2026

Atrial Fibrillation: Rate vs. Rhythm Control and Stroke Prevention

Nov, 26 2025